Cefepime Hydrochloride Pediatric 250mg Vial from Japan
Low-dose 250mg cefepime HCl powder vial for pediatric IV use in neonatal sepsis treatment. Falls under HTS 3004.20.00.71 as measured-dose cefepime salt for prophylactic/therapeutic retail sale. Unmixed product in sterile single-use packaging.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Special pediatric labeling required; check FDA pediatric exclusivity rules
• Dosage verification critical for low-strength variants
• Document reconstitution instructions to confirm therapeutic form